Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

Shawn Cross appointed as chief financial officer for Pacira Biosciences

October 25, 2024 Research and Development Pacira Biosciences

Pacira Biosciences, spcecialist in non-opioid pain therapies, has appointed Shawn Cross as their chief financial officer. In this role, Mr …
Appointment

Stelis, Strides and Steriscience merge to form new CDMO

October 22, 2024 Research and Development CMDO, CPhI, Corporate, bangalore, merger

The CDMO launched earlier this year at the CPHI conference in Milan. The merger is comprised of Stelis Sciences, Strides …
News

Eplontersen recommended for EU approval by CHMP for treatment of hereditary transthyretin-mediated amyloidosis

October 21, 2024 Research and Development CHMP, EMA, EU, Internal Medicine, gene

Wainzua (eplotersen), produced by AstraZeneca and Ionis, has been recommended for approval in the European Union (EU) by the European …
News

Ferring demonstrates effectiveness of a treat-to-target approach in mild-to-moderate ulcerative colitis in first major study

October 3, 2024 Research and Development Ferring Pharmaceuticals, Gastrointestinal tract, ulcerative colitis

1 October 2024 – Saint-Prex, Switzerland – Ferring Pharmaceuticals today announces results from the OPTIMISE study showing the first real-world …
News
Press release
handshake

Strategic alliance announced between Recipharm and Exela

October 1, 2024 Research and Development Corporate, Exela, Recipharm, US

Recipharm and Exela have announced that they have entered into an exclusive strategic alliance. The alliance between the two contract …
News

Santhera Pharmaceuticals announces LIONHEART study results for corticosteroid vamorolone

October 1, 2024 Research and Development Cardiology, Duchenne Muscular Dystrophy, Immunology, Santhera Pharmaceuticals, clinical studies

Santhera Pharma has announced the results of its LIONHEART study, which evaluated vamorolone – a corticosteroid – and confirmed its …
News

Expanded possibilities for laboratory digitalization and connectivity: labforward merges with LabTwin

September 19, 2024 Business Services, Research and Development AI, Corporate, LabTwin, laboratory

The two Berlin-based companies labforward and LabTwin, a subsidiary of the life science group Sartorius, are merging in order to …
News
Press release

Chiesi Global Rare Diseases Launches New Research Grant Initiative to Support Research Excellence in Lysosomal Storage Disorders

September 9, 2024 Research and Development Rare Diseases

9 September 2024, –London, UK –Applications for the independently assessed, expert-led Research Grant Initiative, Find For Rare, are open from …
News
Press release

Amferia closes €1,2 million investment to combat resistant bacterial infections

September 3, 2024 Research and Development Amferia, Chalmers Ventures, Dressings, hosiery & appliances, Hospital Management, Immunology, antimicrobial, investment, peptides

Swedish medtech company Amferia announces the successful completion of its latest investment round, boosting its mission to combat wound infections. …
News
Press release
bowel_cancer_screening

The National Institute for Health and Care Excellence announce technology appraisal guidance recommending risankizumab for adult patients with moderate to severe ulcerative colitis

August 29, 2024 Research and Development AbbVie, Crohns, Gastrointestinal tract, Immunology, NICE, approval, ulcerative colitis

The National Institute for Health and Care Excellence (NICE) have recommended adult patients in England or Wales with moderately or …
News

Leadership Appointments at RQM+

August 28, 2024 Research and Development AI and ML, Corporate, RQM+, appointment

Ronnie Mahofski and Kevin Rowland both become Executive Vice President and General Manager On August 27, MedTech service provider RQM+ announced …
Appointment
lungs

European Commission approves combination chemotherapy for treatment of advanced EGFR-mutated non-small cell lung cancer in adult patients

August 27, 2024 Research and Development J&J, Oncology, chemotherapy, non-small cell lung cancer

Today, Janssen-Cilag International, part of Johnson & Johnson (J&J) has announced that the European Comission (EC) has approved a combined …
News

First oral treatment for hormone-sensitive prostate cancer recommended by NICE

August 15, 2024 Research and Development Accord healthcare, Oncology, Reproductive health, hormone-sensitive, prostate cancer

Today, Accord Healthcare has announced that the National Institute for Health and Care excellence (NICE) have recommended the first oral …
News

FDA approves drug for primary biliary cholangitis

August 15, 2024 Research and Development FDA Approval, FDA approva;, Hepatology, liver, primary biliary cholangitis

Accelerated approval has been granted for Gilead Science’s Livdelzi (seladelpar) to treat primary biliary cholangitis (PBC) by the US Food …
News

Kerato Ltd Partners with University of Montreal to develop novel treatment for corneal damage

August 14, 2024 Research and Development Kerato, Opthalmology, University of Montreal, corenas

BSF the Main Market listed biotech company and owner of corneal tissue replacement company Kerato Ltd, is pleased to announce …
News
Press release
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025